AUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT - USD ($)	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Stock Subscription [Member]	Comprehensive Income [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2022	$ 802,633		$ 17,942,833	$ 136,721	$ 14,599	$ (7,970,510)	$ 10,926,276
Shares, Issued at Mar. 31, 2022	802,633,333
Change in foreign currency					53,274		53,274
Shares issued for cash	$ 385		49,615				50,000
Stock Issued During Period, Shares, New Issues	384,615
Shares issued for settlement of debt	$ 280		136,721	(136,721)			280
Stock Issued During Period, Shares, Other	280,000
Shares issued for services	$ 1,500		319,500				321,000
Stock Issued During Period, Shares, Issued for Services	1,500,000
Shares issued for services - Directors	$ 2,250		479,250				481,500
Stock Issued During Period, Shares, Employee Benefit Plan	2,250,000
Net loss for the period						(2,071,186)	(2,071,186)
Ending balance, value at Mar. 31, 2023	$ 807,048		18,927,919		67,873	(10,041,696)	9,761,144
Shares, Issued at Mar. 31, 2023	807,047,948
Change in foreign currency					(28,013)		(28,013)
Shares issued for settlement of debt	$ 476	$ (476)	157,339				157,339
Stock Issued During Period, Shares, Other	476,000	(476,000)
Shares issued for services	$ 16,088	$ (16,088)	305,652				305,652
Stock Issued During Period, Shares, Issued for Services	16,088,000	(16,088,000)
Shares issued for services - Directors	$ 9,000	$ (9,000)	171,000				171,000
Stock Issued During Period, Shares, Employee Benefit Plan	9,000,000	(9,000,000)
Net loss for the period						(2,374,379)	(2,374,379)
Shares reclaimed into Treasury shares	$ (44,064)	$ 44,064
Stock Issued During Period, Shares, Treasury Stock Reissued	(44,064,000)	44,064,000
Shares issued for exercise of warrants	$ 13,500	$ (13,500)
Stock Issued During Period, Shares, Conversion of Convertible Securities	13,500,000	(13,500,000)
Shares issued for acquisition of Alinova Biosciences	$ 5,000	$ (5,000)	295,000				295,000
Stock Issued During Period, Shares, Acquisitions	5,000,000	(5,000,000)
Shares reclaimed from asset acquisition cancellation	$ (24,000)	$ 24,000	(12,000,000)				(12,000,000)
[custom:StockReclaimedDuringPeriodSharesAcquisitionCancellation]	(24,000,000)	24,000,000
Additional shares reclaimed from asset acquisition cancellation	$ (5,016)	$ 5,016
[custom:StockReclaimedAdditionalDuringPeriodSharesAcquisitionCancellation]	(5,015,996)	5,015,996
Shares issued for conversion of debt	$ 587,500	$ (29,016)	1,762,500				2,320,984
[custom:StockIssuedDuringPeriodSharesConversionOfDebt]	587,499,996	(29,015,996)
Shares issued for services	$ 8,360		21,737				30,097
[custom:StockIssuedDuringPeriodSharesOutsideServices]	8,360,306
Shares issued for services - management	$ 8,771		22,804				31,575
[custom:StockIssuedDuringPeriodSharesInternalServices]	8,770,695
Ending balance, value at Mar. 31, 2024	$ 1,382,663		$ 9,663,951		$ 39,860	$ (12,416,075)	$ (1,329,601)
Shares, Issued at Mar. 31, 2024	1,382,662,949